Discover comprehensive medical information on Albumin, a critical plasma protein used to restore blood volume, treat shock, and manage various medical conditions. Learn about its benefits and administration.
Browse our catalog for available pharmaceutical products and competitive pricing.
Albumin is the most abundant protein found in human blood plasma, constituting approximately 50-60% of total plasma protein. Synthesized primarily by the liver, it plays a crucial role in maintaining oncotic pressure (colloid osmotic pressure), which is essential for regulating fluid distribution between the intravascular and extravascular compartments. Beyond its osmotic functions, Albumin also acts as a vital transport protein, binding and carrying various substances throughout the bloodstream, including hormones, fatty acids, bilirubin, drugs, and other small molecules. Its ability to bind to these substances is critical for their solubility, transport, and metabolism within the body.
The therapeutic use of Albumin dates back to the 1940s, with significant advancements made during World War II when it was recognized for its efficacy in treating shock and burns, particularly its ability to rapidly restore blood volume. The purification and large-scale production of human Albumin from pooled plasma revolutionized its availability as a life-saving medication. Today, it remains a cornerstone in critical care medicine, essential for managing conditions characterized by fluid imbalance and protein deficiency. The development of more refined purification techniques has ensured the safety and reduced the risk of pathogen transmission associated with plasma-derived products, making therapeutic Albumin a highly reliable pharmaceutical compound.
As a pharmaceutical compound, Albumin falls under the drug class of plasma volume expanders and protein replacement solutions. Its primary function as a medication is to replenish circulating plasma volume and to provide protein supplementation in patients with severe deficiency. The anatomical therapeutic chemical (ATC) code for Albumin is B05AA01, categorizing it under 'Blood substitutes and perfusion solutions', specifically 'Blood products and plasma fractions'. This classification highlights its role in directly impacting blood volume and composition, making it indispensable in emergency medicine, surgery, and intensive care units where rapid and effective fluid management is paramount.
The therapeutic efficacy of Albumin is primarily mediated through its potent oncotic properties and its capacity as a versatile transport molecule. When administered intravenously, Albumin molecules, due to their large size and high concentration, exert significant colloid osmotic pressure within the intravascular space. This pressure gradient draws fluid from the interstitial (extravascular) compartment into the capillaries, thereby increasing circulating plasma volume. This fluid shift helps to restore and maintain blood pressure, improve cardiac output, and enhance tissue perfusion, which are critical in conditions like hypovolemic shock, burns, and severe hemorrhage where fluid loss from the vascular system is a major concern. The mechanism is a direct physical effect, counteracting the forces that would otherwise lead to fluid extravasation and edema.
Beyond its role in fluid dynamics, Albumin also functions as a non-specific carrier protein. Its numerous binding sites allow it to transport a wide array of endogenous and exogenous substances. This includes hydrophobic molecules like bilirubin, fatty acids, and steroid hormones, which would otherwise have limited solubility in plasma. Furthermore, Albumin binds to and transports many drugs, influencing their pharmacokinetics, distribution, and duration of action. It also possesses antioxidant properties, can scavenge free radicals, and plays a role in buffering pH. In conditions of severe liver disease or malnutrition, where endogenous Albumin synthesis is impaired, exogenous administration of Albumin not only restores oncotic pressure but also replenishes these crucial transport and protective functions, contributing to overall physiological stability and drug efficacy.
Albumin is a versatile and essential therapeutic agent with a broad range of medical applications, primarily focused on restoring and maintaining intravascular volume, and providing protein replacement in conditions of severe deficiency. Its use is guided by specific clinical situations where its unique properties are critical for patient stabilization and recovery. The decision to administer Albumin is typically based on clinical assessment, laboratory parameters, and the underlying pathological condition.
The dosage and administration of Albumin are highly individualized, depending on the patient's specific condition, age, weight, and response to therapy. It is administered intravenously, typically as a 5% or 25% solution. The rate of infusion can vary significantly, from rapid boluses in emergency situations to slower infusions over several hours, tailored to the clinical need and the patient's cardiovascular status. Close monitoring of vital signs, central venous pressure, and urine output is essential during administration to prevent fluid overload and other complications. Electrolyte balance and renal function should also be regularly assessed.
| Indication | Typical Dose | Frequency | Route |
|---|---|---|---|
| Hypovolemic Shock | 500-1000 mL of 5% solution (or 250-500 mL of 25% solution) | As needed, repeat until stable | Intravenous (IV) |
| Large Volume Paracentesis | 6-8 grams per liter of ascitic fluid removed (e.g., 100 mL of 25% solution per 5L removed) | Single dose post-paracentesis | Intravenous (IV) |
| Severe Burns | Dose calculated based on burn surface area and patient weight, typically 0.5-1 g/kg/day | Continuous infusion or divided doses | Intravenous (IV) |
| Hypoalbuminemia (chronic) | 25 g (100 mL of 25% solution) | Once daily or every other day, as directed | Intravenous (IV) |
Important: Always follow your prescriber instructions. Dosages vary by weight, age, and condition.
While generally well-tolerated, Albumin administration can be associated with certain side effects. These are typically mild and transient but can occasionally be more serious, especially with rapid infusion or in susceptible individuals. Awareness of these potential reactions is important for safe clinical practice.
While Albumin itself is generally not known for significant direct drug-drug interactions that alter its own metabolism, its role as a major transport protein means it can indirectly influence the pharmacokinetics of many co-administered medications. This is particularly relevant for highly protein-bound drugs, where changes in Albumin levels or competition for binding sites can alter the free (active) drug concentration.
Medical Disclaimer: This information is for educational purposes only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.
Albumin is generally not intended for chronic, long-term use as a primary therapy, but rather for acute or subacute conditions requiring rapid volume expansion or protein replacement. In certain chronic conditions like advanced liver disease, intermittent Albumin infusions may be part of a long-term management strategy, but this is always under strict medical supervision and tailored to individual patient needs. The safety of long-term use depends heavily on the underlying condition and the patient's overall health status.
Albumin is administered intravenously and its absorption or efficacy is not affected by food intake. Patients can continue their regular diet as tolerated unless otherwise instructed by their healthcare provider due to their underlying medical condition or other concurrent treatments.
Albumin is typically administered in a hospital or clinical setting by healthcare professionals. It is not a medication that patients self-administer at home. Therefore, missing a dose is highly unlikely. If there are concerns about the timing or administration of Albumin, it is crucial to communicate immediately with the attending medical staff or prescribing physician.
Albumin is a prescription-only medication and a plasma-derived product. It is not available for over-the-counter purchase. It must be administered by a qualified healthcare professional in a medical setting, such as a hospital, clinic, or infusion center, under strict medical supervision. To obtain Albumin, a valid prescription from a licensed physician is required, and it must be sourced through licensed pharmaceutical distributors and medical channels to ensure its safety, quality, and proper storage.